The Europe Orthokeratology Lens Market is expected to witness market growth of 5.9% CAGR during the forecast period (2022-2028).
Refractory error and visual impairments may impact a large number of people worldwide. The general public's well-being is greatly impacted by refractive errors and visual impairments, which has increased the demand for efficient treatment methods. The general population's increasing propensity for refractive errors increased the demand for orthokeratology procedures. Additionally, the risk factors for microbial keratitis were decreased and the process' efficiency was increased due to the quick development of technical knowledge. Also, orthokeratology has outperformed the conventional approach in halting the progression of myopia.
The general population's rising per capita healthcare spending has also raised the use of orthokeratology operations and contributed to the market's rapid expansion. It is further backed by rising healthcare costs and government reimbursement regulations that resulted in significant growth over the projection period. It makes use of breathable rigid lens material & everts geometry designs. Orthokeratology is currently most frequently used in clinical settings to eliminate myopia by flattening the cornea.
The widespread availability of optometrists, increased use of cutting-edge orthokeratology lenses, and a rise in myopia prevalence are all likely to contribute to the orthokeratology lens market's expansion in this Europe region. It is much simpler to launch a new product in Europe than it is in the US or China, especially if it is ground-breaking and innovative. A product must have the CE certification in order to be marketed in Europe. It ensures that the manufacturer's product complies with all relevant European Community directives. This is considered proof to the users that the CE-approved ortho-K lenses are reliable and safe to use.
The Germany market dominated the Europe Orthokeratology Lens Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $59.8 Million by 2028. The UK market is anticipated to grow at a CAGR of 5% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 6.7% during (2022 - 2028).
Based on Product Type, the market is segmented into Overnight Ortho-K lenses and Day-time Ortho- K lenses. Based on Indication, the market is segmented into Myopia, Presbyopia Hypermetropia and Astigmatism. Based on Distribution Channel, the market is segmented into Ophthalmology Clinics, Optometry Clinics, Hospitals, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Bausch Health Companies, Inc., The Cooper Companies, Inc., Euclid Systems Corporation, Alpha Corporation, Inc. (Menicon Co., Ltd.), Brighten Optix Corporation, TruForm Optics, Inc., Art Optical Contact Lens, Inc., and MiracLens, LLC.
Refractory error and visual impairments may impact a large number of people worldwide. The general public's well-being is greatly impacted by refractive errors and visual impairments, which has increased the demand for efficient treatment methods. The general population's increasing propensity for refractive errors increased the demand for orthokeratology procedures. Additionally, the risk factors for microbial keratitis were decreased and the process' efficiency was increased due to the quick development of technical knowledge. Also, orthokeratology has outperformed the conventional approach in halting the progression of myopia.
The general population's rising per capita healthcare spending has also raised the use of orthokeratology operations and contributed to the market's rapid expansion. It is further backed by rising healthcare costs and government reimbursement regulations that resulted in significant growth over the projection period. It makes use of breathable rigid lens material & everts geometry designs. Orthokeratology is currently most frequently used in clinical settings to eliminate myopia by flattening the cornea.
The widespread availability of optometrists, increased use of cutting-edge orthokeratology lenses, and a rise in myopia prevalence are all likely to contribute to the orthokeratology lens market's expansion in this Europe region. It is much simpler to launch a new product in Europe than it is in the US or China, especially if it is ground-breaking and innovative. A product must have the CE certification in order to be marketed in Europe. It ensures that the manufacturer's product complies with all relevant European Community directives. This is considered proof to the users that the CE-approved ortho-K lenses are reliable and safe to use.
The Germany market dominated the Europe Orthokeratology Lens Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $59.8 Million by 2028. The UK market is anticipated to grow at a CAGR of 5% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 6.7% during (2022 - 2028).
Based on Product Type, the market is segmented into Overnight Ortho-K lenses and Day-time Ortho- K lenses. Based on Indication, the market is segmented into Myopia, Presbyopia Hypermetropia and Astigmatism. Based on Distribution Channel, the market is segmented into Ophthalmology Clinics, Optometry Clinics, Hospitals, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Bausch Health Companies, Inc., The Cooper Companies, Inc., Euclid Systems Corporation, Alpha Corporation, Inc. (Menicon Co., Ltd.), Brighten Optix Corporation, TruForm Optics, Inc., Art Optical Contact Lens, Inc., and MiracLens, LLC.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Overnight Ortho-K lenses
- Day-time Ortho- K lenses
By Indication
- Myopia
- Presbyopia
- Hypermetropia
- Astigmatism
By Distribution Channel
- Ophthalmology Clinics
- Optometry Clinics
- Hospitals
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
- Bausch Health Companies, Inc.
- The Cooper Companies, Inc.
- Euclid Systems Corporation
- Alpha Corporation, Inc. (Menicon Co., Ltd.)
- Brighten Optix Corporation
- TruForm Optics, Inc.
- Art Optical Contact Lens, Inc.
- MiracLens, LLC
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Europe Orthokeratology Lens Market by Product Type
Chapter 5. Europe Orthokeratology Lens Market by Indication
Chapter 6. Europe Orthokeratology Lens Market by Distribution Channel
Chapter 7. Europe Orthokeratology Lens Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
- Bausch Health Companies, Inc.
- The Cooper Companies, Inc.
- Euclid Systems Corporation
- Alpha Corporation, Inc. (Menicon Co., Ltd.)
- Brighten Optix Corporation
- TruForm Optics, Inc.
- Art Optical Contact Lens, Inc.
- MiracLens, LLC
Methodology
LOADING...
